{"chunk_id": "The-Pregnancy-and-Lactation-Labeling-Rule-(PDF---656KB)__chunk_24", "source": "The-Pregnancy-and-Lactation-Labeling-Rule-(PDF---656KB)", "text": "organogenesis at doses up to 40 and 20 times the maximum \nrecommended human dose (MRHD), respectively, resulted in decreased \nfetal body weight gain and delayed skeletal ossification but no teratogenic \neffects were observed. Decreased fetal body weight and delayed skeletal \nossification were not observed at doses up to 10 and 5 times the MRHD in \nrats and rabbits, respectively [see Data].  \nThe estimated background risk of major birth defects and miscarriage for \nthe indicated population is unk"}